Vascular effects of sustained-release fibroblast growth factors

Annals of Otology, Rhinology and Laryngology

Volumn 105, Issue 2, 1996, Pages 109-116

  Hom, David B ^a,c   Medhi, Khawar ^a,c   Assefa, Girma ^a,c   Juhn, Steven K ^a,c   Johnston, Thomas P ^b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Box 396 ^*

Author keywords

growth factors; neovascularization; surgical flaps; wound healing

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; DRUG VEHICLE; ENDOTHELIAL CELL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GELFOAM; GROWTH FACTOR; HEPARIN; POLOXAMER; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; ENDOTHELIUM CELL; IRRADIATION; NONHUMAN; PHARMACEUTICS; PRIORITY JOURNAL; RABBIT; SKIN FLAP; SUSTAINED RELEASE PREPARATION; VASCULARIZATION; WOUND HEALING;

EID: 0030024821     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949610500205     Document Type: Article

References (36)

1. Klein-Soyer C, Beretz A, Cazenave JP, Driot F, Maffrand J. Behavior of confluent endothelial cells after irradiation. Modulation of wound repair by heparin and acidic fibroblast growth factor. Biol Cell 1990;68:231-8.
2. Horn D, Assefa G, Song CW. Endothelial cell growth factor (ECGF) application to irradiated soft tissue. Laryngoscope 1993;103:165-70.
3. Thompson JA, Anderson KA, DiPietro JM, et al. Site-directed neovessel formation in vivo. Science 1988;241:1349-52.
4. Hay ward PG, Alison WE, Carp SS, Hui PS, Robson MC. Local infiltration of an angiogenic growth factor does not stimulate the delay phenomenon. Br J Plast Surg 1991;44:526-9.
5. Im MJ, Kim YS, Edwards RJ, Hoopes JE, Fenselau A. The effect of bovine basic fibroblast growth factor on skin flap survival in rats. Ann Plast Surg 1992;28:242-5.
6. Ishiguro N, Yabe Y, Shimizu T, Iwata H, Miura T. Basic fibroblast growth factor has a beneficial effect on the viability of random skin flaps in rats. Ann Plast Surg 1994;32:356-60.
7. Khouri RK, Brown DM, Leal-Khouri SM, Tark KC, Shaw WW. The effect of basic fibroblast growth factor on the neovascularization process: skin flap survival and staged flap transfers. Br J Plast Surg 1991;44:585-8.
8. Uhl E, Barker JH, Bondar I, Galla TJ, Lehr HA, Messmer K. Improvement of skin flap perfusion by subdermal injection of recombinant human basic fibroblast growth factor. Ann Plast Surg 1994;32:361-5.
9. Johnston TP, Punjabi MA, Froelich CJ. Sustained delivery of interleukin-22 from a poloxamer 407 gel matrix following intraperitoneal injection in mice. Pharm Res 1992;9:421-30.
10. Fults KA, Johnston TP. Sustained release of urease from a poloxamer gel matrix. J Parenter Sci Technol 1990;44:558-65.
11. Johnston TP, Miller SC. Toxicological evaluation of poloxamers for intramuscular use. J Parenter Seci Technol 1985;39:83-8.
12. Pec EA, Wout Z, Johnston TP. Biological activity of urease formulated in poloxamer 407 following intraperitoneal injection in the rat. J Pharm Sci 1992;81:626-30.
13. Tan EL, Shah HS, Leister KJ, et al. Transforming growth factor-α (TGF-α) in a semisolid dosage form: preservative and vehicle selection. Pharm Res 1993;10:1238-42.
14. Rifkin DB, Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 1989;109:1-6.
15. Schreiber A, Kenney J, Kowalski W, Friesel R, Mehlman T, Maciag T. Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition. Proc Natl Acad Sci U S A 1985;82:6138-42.
16. Gospodarowicz D, Cheny J. Heparin protects basic and acid FGF from inactivation. J Cell Physiol 1986;128:475-84.
17. Hom DB, Assefa G. Effects of endothelial cell growth factor on vascular compromised skin flaps. Arch Otolaryngol Head Neck Surg 1992;118:624-8.
18. Dimitrievich GS, Fischer-Dzoga K, Griem M. Radiosensitivity of vascular tissue. I. Differential radiosensitivity of capillaries: a quantitative in vivo study. Radiat Res 1984;99:511-35.
19. Patterson TJ, Berry RJ, Hopewell JW, Wiernek G. The effect of radiation in survival of experimental skin flaps. In: Grabb WC, Myers MB, eds. Skin flaps. Boston, Mass: Little, Brown, 1975:39-46.
20. Erol O, Spira M, Levy B. Microangiography: a detailed technique of perfusion. J Surg Res 1980;29:406-13.
21. Fried M, Horowitz Z, Kelly J, Strome M. The importance of the pedicle for the survival of a vascularized free flap: an experimental study on rats. Head Neck Surg 1982;5:130-3.
22. Klingbeil CK, Cesar LB, Fiddes JC. Basic fibroblast growth factor accelerates tissue repair in models of impaired wound healing. Prog Clin Biol Res 1991;365:443-58.
23. Lobb RR, Alderman EM, Fett HW. Induction of angiogenesis by bovine brain derived class 1 heparin-binding growth factor. Biochemistry 1985;24:4969-73.
24. Wang P, Johnston TP. Thermal-induced denaturation of two model proteins: effect of poloxamer 407 on solution stability. Int J Pharm 1993;96:41-9.
25. Wang P, Johnston TP. Enhanced stability of two model proteins in an agitated solution environment using poloxamer 407. J Parenter Sci Technol 1993;47:183-9.
26. Hom D, Baker S, Graham LM, McClatchey KD. Utilizing angiogenic agents to expedite the neovascularization process in skin flaps. Laryngoscope 1988;98:521-6.
27. Matuszewska B, Keogan M, Fisher DM, et al. Acidic fibroblast growth factor evaluation of topical formulations in a diabetic mouse wound healing model. Pharm Res 1994;11:65-71.
28. Kleiman LA, Hasslinger B, Eddy H, Suter C, Blanchard C, Gray W. The effects of carbocisplatinum and radiation on skin flap survival. Arch Otolaryngol 1992;118:68-73.
29. Nemiroff PM, Merwin GE, Brant T, Cassisi NJ. Effects of hyperbaric oxygen and irradiation on experimental skill flaps in rats. Otolaryngol Head Neck Surg 1985;93:485-91.
30. Weisman RA, Blumberg AL, Brousseau DA, Harford WE, Silverman DG. Fluorometric assessment of skin flap viability in the rat: effect of radiation therapy. Otolaryngol Head Neck Surg 1983;91:151-5.
31. Downs EC, Robertson NE, Riss T, Plunkett ML. Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro. J Cell Physiol 1992;152:422-9.
32. Yerushalmi N, Arad A, Margalit R. Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in woundhealing. Arch Biochem Biophys 1994;313:267-73.
33. Roy F, DeBlois C, Doillon CJ. Extracellular matrix analogs as carriers for growth factors: in vitro fibroblast behavior. J Biomed Mater Res 1993;27:389-97.
34. Langer R. Delivery systems for angiogenesis stimulators and inhibitors. EXS 1992;61:327-30.
35. Anderson PM, Hanson DC, Hasz DE, Halet MR, Blazar BR, Ochoa AC. Cytokines in liposomes: preliminary studies with IL-1, EL-2, IL-6, GM-DSF and interferon-gamma. Cytokine 1994;6:92-101.
36. Langer R, Moses M. Biocompatible controlled release polymers for delivery of polypeptides and growth factors. J Cell Biochem 1991;45:340-5.